MyHeart

  • Home
  • About Us
    • Our Team
    • Authors
  • Resources
    • MitraClip University
      • Advanced Steering
    • POTS Center
    • Heart Healthy Nutrition
    • MyHeart Videos
  • Articles
  • Podcasts
  • Contact Us
  • Advertising
Home / Heart Disease / Coronary Artery Disease / Surviving a Heart Attack: the Big One!

Surviving a Heart Attack: the Big One!

May 22, 2017 by Alain Bouchard, MD 5 Comments

The widow maker heart attack, also known as “the big one”,  is an acute occlusion of the left anterior descending (LAD) artery that can lead to severe heart muscle damage and/or death.  If not treated in a timely matter, surviving a heart attack of this magnitude is very difficult. While visiting Austin, Texas, my wife and I came across the southwest version of the widow maker.  This version is a bronze statue displayed in the Driskill Hotel, by Barvo Walker depicting a runaway horse  with a cowboy’s foot caught in the stirrup dragging him as it runs away.  His partner’s only option is to shoot the runaway horse and save the cowboy or he will surely meet his demise.

I do not know much about riding a horse, but I have treated several patients with  widow maker heart attacks:” the big one”. I would like to share the experience of three patients that have survived a widow maker heart attack, but they all have different outcomes dependent upon lifestyle choices and treatment. During  the acute phase of the heart attack, the artery is occluded by a thrombus or blood clot.  The lack of blood supply to the heart muscle causes myocardial cell death and progressive loss of cardiac muscle function. Structural changes in the heart muscle leads to left ventricular remodeling with enlargement of the left ventricle and development of congestive heart failure. When treating a heart attack patient, our primary goal is to relieve myocardial ischemia by reopening the occluded artery as quickly as possible so that we can limit the infarct size. We also prescribe medications that reduce the cardiac work and prevent complications such as reocclusion of the artery and development of  heart failure. Also, I wanted to provide some insight into the future treatment of patients with myocardial infarction and include a patient that had undergone a “first-in-man” study of allogenic stem cell therapy.

The first patient is in his late forties. He suffered his first widow maker heart attack at the age of 40. He presented at 3:00 am and he was rushed to the cath lab at BBH Princeton where arteriograms are performed. He had a widow maker heart attack, the”big one”and we were able to reopen his artery in 42 minutes. He was treated with a coronary stent but had suffered some heart damage. His left ventricular function was reduced at 30% (normal ejection fraction is 50-55%). The patient continued to smoke and he was non-compliant with his medications. He had hyperlipidemia and hypertension.  He presented again in April 2017 with prolonged chest pain. He had been hurting for 13 hours prior to  coming to the hospital. He was brought  to the cath lab and found again to have a proximal occlusion of the LAD.

Arteriogram showing an occluded widowmaker (LAD) coronary artery

Arteriogram showing patency after stenting the widowmaker (LAD)
Despite the fact that his artery was reopened within 60 minutes, he had waited so long that his heart substantiated significant amount of damage and his left ventricular function was further reduced this time at 20%.  With an EF of 20%, he is now at increased risk of heart failure and sudden cardiac death.  He will likely need an implantable cardioverter defibrillator, or ICD.

 

 

The second patient is a good friend and I have known him for over 25 years. He is an avid cyclist and has always taken care of himself. He does have a family history of heart disease and has  hyperlipidemia. In July 2016 while riding his bike, he started experiencing some chest pain. He immediately sought medical attention and presented at BBH Brookwood Hospital where he was taken to the cath lab within an hour and a half of the onset of chest pain. He was found to have a widow maker heart attack, the “big one” with a proximal occlusion of the LAD and was treated with coronary stenting.

 

Unfortunately, 2 hours later he was taken back to the cath lab because of  ongoing  chest pain. He was found to have an acute occlusion of his stent and he was treated with further balloon angioplasty and with another coronary stent. His artery had a lot of calcium and it is probable that the first stent closed because of malapposition or not complete expansion of the stent. In any case, an intra-aortic balloon pump was placed and he was kept in the ICU overnight. He was discharged 2 days later and his heart function in the hospital was measured at 30 to 35%. I saw him in the office two weeks later and he was recovering nicely. He was still exercising every day but at a very mild pace on his stationary bike. His echocardiogram performed at that time showed remarkable recovery with an ejection fraction estimated at 40-45 percent. I walked him on the treadmill and he was even able to run without having chest pain. We discussed the possibility of a stem-cell protocol for patients that have suffered a myocardial infarction.

 

 

It turns out,  however, that he had already undergone stem-cell treatment a year and a half prior. He had been treated by an orthopedic surgeon for arthritis of his knee. He underwent an autologous stem-cell treatment from stem cells that were taken out of his hip and injected into his knee, and for this reason, we could not enroll him in our protocol. We performed an MRI of his heart and found that he had only a small residual damage from his widow maker heart attack and it was astounding to me to find that exercise, physical conditioning, and possibly his own stem cells had mitigated significant damage to his heart and hastened his recovery. The impact of exercise training on cardiac remodeling has been the subject of extensive study. Work on two dimensional echocardiography demonstrated a high prevalence of left ventricular hypertrophy and dilatation. Endurance type exercise, such as cycling, running or swimming, involves sustained elevation in cardiac output with normal to low peripheral vascular resistance causing a volume challenge for the heart and cardiac remodeling. It is possible to think that an increase in myocardial reserve may have contributed to limit the damage caused by the heart attack and hastened recovery.

 

The third  patient is a 55-year-old nonsmoker  with a history of   diabetes and hyperlipidemia. In 2009 he suffered a widow maker heart attack or the “big one”, with an occlusion of his proximal LAD that was treated with a coronary stent within 78 minutes of presentation to BBH Princeton Hospital.

 

Two days later he was brought back to the cath lab and treated with an intra-coronary infusion of stem-cells as part of a research protocol. This was a “first-in-man”, adventitial delivery of an allogenic bone marrow derived adherent stem cell (Multistem, Athersys Inc.) in patients, 3-5 days post large myocardial infarction and reduced left ventricular function (ejection fraction < 35%). He underwent 2 injections, each of 25 million stem-cells  in the middle portion of the LAD.

 

He recovered well in 2014 and had a thallium stress test  performed  showing that he had a small antero-apical scar with mild peri-infarction ischemia and ejection fraction of 48%. In July 2016 he presented to the hospital with a 30 minute episode of chest pain. He had symptoms that were similar to his previous myocardial infarction but he had no further pain upon arrival. His troponin enzymes were negative, indicating absence of new damage. Because he was on a blood thinner, coronary arteriogram was performed 2 days later, and despite the fact that he was pain-free, he was found to have a widow maker blockage with proximal occlusion of the LAD with collateral flow from the left circumflex. The patient again underwent percutaneous intervention and another stent was placed.

 

 

He is currently doing well with his heart function with only minimally reduced ejection fraction  at 45%. Again in this case,  it is remarkable to see very minimal damage and great recovery post myocardial infarction. It is possible to think that stem-cell treatment of his widow maker heart attack may have hastened his recovery and equipped him with tools, such as collateral arteries formed by his own body, that may have prevented further damage. In the study that he was participating in 2009, it was reported that patients similar to him had an average of 13% increase in actual ejection fraction measurement and an average of 25% increase in left ventricular stroke volume. It has been postulated that the effects of Multistem are modulated by paracrine factors and exert some anti-inflammatory and angiogenic properties. Our patient had developed a collateral system that protected him from developing new injury on his second presentation, something he did not have in 2009. We are currently studying the effect of allogenic bone-marrow derived stem cells in the setting of Non-Stemi at BBH Princeton. This will be the focus of our next article at Myheart.net.

4.95/5 (376)

Tell Us How We're Doing...

Filed Under: Coronary Artery Disease, Heart Disease Tagged With: angiogram, arteriogram, cath, catheterization, coronary artery disease, heart attack, heart disease, Heart failure, LAD, left anterior descending artery, left ventricle, stem cells, stent, widow maker, widowmaker

Comments

  1. Sondra Baker says

    December 5, 2018 at 5:17 pm

    2 yrs. ago I had an angiogram that showed a 60% blockage in my lft. atrium. How signifcant does it have to be before it requires a procedure or poses a significant danger of having a heart attack?

    Reply
  2. Boyet au says

    May 8, 2019 at 6:54 am

    Hi doctor..when is the safest period after bypass surgery you can say that the patient can now live normal life?

    Reply
    • Dr. Mustafa Ahmed says

      May 20, 2019 at 4:02 am

      If symptoms are stable then very early on, particularly after healing of the surgical access sites. Cardiac rehab can help to answer these issues.

      You can follow our twitter at @MustafaAhmedMD

      Disclaimer: The comment response is opinion and in no way affiliated with my employer. It is a vague response that is not to be used as direct medical advice and in no way should replace the opinion of a medical provider.

      Reply
  3. Boyet au says

    May 16, 2019 at 8:45 am

    Good day doctor…is lima to lad single bypass alone without any other vein grafts can also occluded? I read a lots of articles saying that only saphenous vein are likely to occlude over time and lima to lad has excellent patency rate

    Reply
    • Dr. Mustafa Ahmed says

      May 19, 2019 at 5:58 am

      LIMA patency rates are excellent and if the operation done well can last a remarkably long time.

      You can follow our twitter at @MustafaAhmedMD

      Disclaimer: The comment response is opinion and in no way affiliated with my employer. It is a vague response that is not to be used as direct medical advice and in no way should replace the opinion of a medical provider.

      Reply

Leave a Reply Cancel reply

Connect with:
Facebook Google Twitter
If you need immediate medical attention, please call 911. These comments are not guaranteed to be read in a timely manner and should not be used to seek immediate medical advice.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Alain Bouchard, MD

Dr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at St. Vincent's Health System, Ascension.

View My Posts

Recent Posts

  • Reasons for Geographic And Racial Difference in Strokes
  • IN “REGARDS” TO THE STROKE BELT.
  • Arts in Medicine with Kimberly Kirklin at UAB and Dr Rachel Easterwood in New York
  • THE CHRONIC LEAKY MITRAL VALVE
  • Leaky Mitral Valve

Categories

  • Aortic disease (7)
  • Featured Articles (65)
  • General Health (38)
    • Complementary Medicine (1)
  • Heart Disease (176)
    • Cardiac Arrhythmias (17)
    • Coronary Artery Disease (51)
    • Heart Failure and Cardiomyopathies (29)
    • Heart Valves (46)
  • Heart Health (112)
    • Diet & Nutrition (36)
    • Exercise (34)
    • Risk & Prevention (54)
  • Medical News (9)
  • Podcast (65)
  • Tests & Investigations (28)
  • Uncategorized (3)
  • Vascular Disease (27)
    • Hypertension (High Blood Pressure) (14)
RECENT POSTS
  • Reasons for Geographic And Racial Difference in Strokes
  • IN “REGARDS” TO THE STROKE BELT.
  • Arts in Medicine with Kimberly Kirklin at UAB and Dr Rachel Easterwood in New York
  • THE CHRONIC LEAKY MITRAL VALVE
  • Leaky Mitral Valve
FOLLOW US
ABOUT MY HEART

MyHeart is a group of physicians dedicated to empowering patients to take control of their health. Read by over a million people every year, MyHeart is quickly becoming a “go to” resource for patients across the world.

POPULAR TOPICS ON MYHEART
  • POTS Syndrome Center
  • Earlobe Crease & Heart Disease
  • Atrial Fibrillation with RVR
  • STEMI
  • MitraClip
  • Mitral Regurgitation
NAVIGATION
  • Home
  • About Us
    • Our Team
    • Authors
  • Resources
    • MitraClip University
      • Advanced Steering
    • POTS Center
    • Heart Healthy Nutrition
    • MyHeart Videos
  • Articles
  • Podcasts
  • Contact Us
  • Advertising

Privacy Policy. Terms of Use.
© 2023 MyHeart. All rights reserved.
MyHeart is not a substitute for advice from a doctor. Read our medical disclaimer. Sitemap.